The invention relates to a method for diagnosis and/or diabetic complications and/or risk assessment of pancreatic diabetes, in particular of diabetic sequelae, wherein a determination of the marker procalcitonin (PCT: SEQ ID No. 1) or a partial peptide or fragment thereof or if contained in a marker combination (Panel, Cluster) is carried out on a patient within normal value ranges of leucocytes under investigation. The invention further relates to invent new drugs, a diagnostic device and a kit for carrying out said method.
展开▼
机译:本发明涉及一种用于诊断和/或糖尿病并发症,和/或风险评估的胰腺糖尿病,特别是糖尿病后遗症的方法,其中测定标志降钙素(PCT:SEQ ID No.1)或部分肽或片段在所研究的白细胞的正常值范围内,对患者进行上述检测或如果其包含在标记组合中(面板,簇)。本发明还涉及发明新药物,用于执行所述方法的诊断装置和套件。
展开▼